Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1976-11-11
1978-05-09
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 232306, 424 12, A61K 4300, G01N 3316
Patent
active
040887464
ABSTRACT:
This invention provides a method for the radioimmunoassay of thyroid-stimulating hormone which utilizes a rapid and convenient version of a double antibody procedure. Highly purified second antibody is bound, by means of covalent bonds, to hydrolyzed polyacrylamide particles to produce a two-phase system. The solid phase comprises immobilized second antibody bound to the reaction product of labeled and unlabeled thyroid-stimulating hormone with the first antibody (first antibody-antigen complex) and the liquid phase comprises free (unbound) labeled and unlabeled thyroid-stimulating hormone. The two phases are separated and the radioactivity of either phase is measured.
REFERENCES:
patent: 3853987 (1974-12-01), Dreyer
patent: 4021534 (1977-05-01), Lafontaine
Koninckx et al, Acta Endocrinologica, vol. 81, No. 1, Jan., 1976, pp. 43-53.
Sluiter et al, Clinica Chimica Acta, vol. 42, Nov., 1972, pp. 255-262.
Blakemore Judith I.
Burgett Michael W.
Lewin Nathan
Bio-Rad Laboratories, Inc.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Radioimmunoassay for thyroid-stimulating hormone (TSH) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioimmunoassay for thyroid-stimulating hormone (TSH), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioimmunoassay for thyroid-stimulating hormone (TSH) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2357687